Task: Answer the multiple-choice question.
Question: Which drug exhibits a -6.989\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CC(OC(=O)c1cc(S(=O)(=O)N2CCOCC2)ccc1F)C(=O)NC1CCCC1
b) CCNc1nc(NCC)n2c(SCC(=O)Nc3ccccc3F)nnc2n1
Answer: b. CCNc1nc(NCC)n2c(SCC(=O)Nc3ccccc3F)nnc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCNc1nc(NCC)n2c(SCC(=O)Nc3ccccc3F)nnc2n1
CCNc1nc(NCC)n2c(SCC(=O)Nc3ccccc3F)nnc2n1
2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-(2-fluorophenyl)acetamide